Bioforce Nanosciences Holdings, Inc.
BFNH· OTC
Filed May 4, 2020 · 10-Q · 34 days after period end · 0001091818-20-000107
| Metric | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|
| Revenue | — | $5.85K | — |
| Net Income | -$158.04M | -$12.85K | -$23.97K |
| EPS Diluted | -$10.35 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioforce Nanosciences Holdings, Inc. · CIK 1310488 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 4, 2020 · 34 d after period end